Singapore: CSL Biotherapies, a subsidiary of CSL Limited, has been awarded a contract by the US Department of Health and...
Singapore: The Korean Food and Drug Administration (KFDA) has approved Australia-based medical device firm Nanosonics' ...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
Singapore: Boehringer Ingelheim has acquired investigational drug PXS4728A from Australia based Pharmaxis, to develop it...
Singapore: Australia based, Circadian Technologies, through its wholly owned subsidiary Opthea has recieved USFDA approv...
Singapore: AusBiotech and Korea Biotechnology Industry Organization (KoreaBIO) are signing a memorandum of understanding...
Singapore: In a bid to reduce the soaring cases of skin cancer in the country, many states of Australia are set to ban c...
Singapore: Australian biomedical company Allied Healthcare launched cardiovascular tissue patch, CardioCel, to surgicall...
Singapore: Peanut allergy is one of the most dreaded forms of allergies across the globe. It is recognized as some of th...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA)'s Abraxane (nanoparticle album...
Singapore: Australian vaccine development company BioDiem has been grated a key European patent for its synthetic antim...
Singapore: Prana Biotechnology has raised $6 million (A$6 million) approximately through a placement of 32,500,000 ordin...
AusBiotech, which is Australian biosciences' flagstaff industry organization comprising of a network of over 3,000 life ...
Singapore: Smart phones are the preferred tool for patient's engagement and communication with their healthcare provider...
Singapore: ResMed reported a record revenue of $371.9 million, a nine percent increase (and a 13 percent rise on a const...
Singapore: At the 20th International AIDS Conference (AIDS 2014) being held in Melbourne from July 20th-25th, India HIV/...
Singapore: Australian drug delivery company, Phosphagenics, has raised $11.45 million of its $15.29 million capital rais...
Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/I...
